-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Chromocell Therapeutics Corp quarterly/annual General and Administrative Expense history and growth rate from 2023 to 2024.
- Chromocell Therapeutics Corp General and Administrative Expense for the quarter ending March 31, 2024 was $788 K, a 64.9% increase year-over-year.
- Chromocell Therapeutics Corp annual General and Administrative Expense for 2023 was $2.74 M, a 149% increase from 2022.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)